ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

Mark Israel To Direct Norris Cotton Center

October 19, 2001

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

February 28, 2014

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored

July 4, 1997

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

SBIR Priority Score Median Must Match R01s Under House Bill

June 28, 1996